BMJ  2005;330 (8 January), doi:10.1136/bmj.330.7482.0-d

Decision makers need to judge credibility of economic evaluations

Cost effectiveness assessments submitted to the technology appraisal programme of the National Institute for Clinical Excellence (NICE) by manufacturers of the relevant healthcare technologies differ significantly from those contracted by university based assessment groups. Miners and colleagues (p 65) retrospectively compared 62 appraisals. Manufacturers' estimates of incremental cost effectiveness ratios were lower (suggesting a more cost effective use of resources) than those produced by the assessment groups (25 were lower, 29 were the same, none were higher; P < 0.01).

Credit: IMX/REX

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study

A H Miners, Martina Garau, Dogan Fidan, and A J Fischer
BMJ 2005 330: 65. [Abstract] [Full Text] [PDF]